Individual-Reader Diagnostic Performance and Between-Reader Agreement in Assessment of Subjects with Parkinsonian Syndrome or Dementia Using <sup>123</sup>I-Ioflupane Injection (DaTscan) Imaging
John Seibyl(Elucid Bioimaging), Igor D. Grachev(Teva Pharmaceuticals (United States)), Jacques Darcourt(Centre Antoine Lacassagne), John T. O’Brien(North Tyneside General Hospital), Rudi Dierckx(University Medical Center Groningen), Klaus Tatsch(Städtisches Klinikum Karlsruhe), Jan Booij(University of Amsterdam), Donald G. Grosset(University of Glasgow), Eduardo Tolosa(Biomedical Research Networking Center on Neurodegenerative Diseases), Robert A. Hauser(University of South Florida), Zuzana Walker(South Essex Partnership University Foundation NHS Trust), Kenneth Marek(University of Pennsylvania), Andreas Kupsch(University of Namur), Ian G. McKeith(Newcastle Hospitals - Campus for Ageing and Vitality), Nin Bajaj(Nottingham University Hospitals NHS Trust), Durval C. Costa(Champalimaud Foundation)
Cited by 22
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
The Parkinson Progression Marker Initiative (PPMI)
|Progress in Neurobiology|2011|1.9k
MDS research criteria for prodromal Parkinson's disease
|Movement Disorders|2015|1.3k